IGMS

IGM Biosciences (IGMS)

IGM Biosciences Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IGMS

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/29	20 : 00	GlobeNewswire Inc.	IGM Biosciences to Present at the Jefferies Healthcare Conference	NASDAQ:IGMS	IGM Biosciences Inc
2024/05/09	05 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IGMS	IGM Biosciences Inc
2024/05/09	05 : 10	GlobeNewswire Inc.	IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:IGMS	IGM Biosciences Inc
2024/05/09	05 : 05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:IGMS	IGM Biosciences Inc
2024/05/07	20 : 00	GlobeNewswire Inc.	IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference	NASDAQ:IGMS	IGM Biosciences Inc
2024/04/17	21 : 30	GlobeNewswire Inc.	IGM Biosciences Announces Refocusing of Sanofi Collaboration	NASDAQ:IGMS	IGM Biosciences Inc
2024/04/10	20 : 00	GlobeNewswire Inc.	IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum	NASDAQ:IGMS	IGM Biosciences Inc
2024/03/08	06 : 27	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:IGMS	IGM Biosciences Inc
2024/03/08	06 : 10	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IGMS	IGM Biosciences Inc
2024/03/08	06 : 10	GlobeNewswire Inc.	IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:IGMS	IGM Biosciences Inc
2024/03/06	09 : 34	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2024/02/01	21 : 00	GlobeNewswire Inc.	IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference	NASDAQ:IGMS	IGM Biosciences Inc
2024/01/08	23 : 00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IGMS	IGM Biosciences Inc
2024/01/04	10 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2024/01/04	08 : 17	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2024/01/04	08 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2024/01/03	21 : 00	GlobeNewswire Inc.	IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/16	09 : 20	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/16	09 : 19	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/16	09 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/14	07 : 36	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/14	07 : 33	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/14	07 : 30	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/14	07 : 27	Edgar (US Regulatory)	Form 144 - Report of proposed sale of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/09	06 : 05	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/06	06 : 01	GlobeNewswire Inc.	IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/02	09 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/02	09 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/02	09 : 01	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:IGMS	IGM Biosciences Inc
2023/12/01	19 : 32	PR Newswire (US)	Bulletin from Extraordinary General Meeting in Medivir AB (publ)	NASDAQ:IGMS	IGM Biosciences Inc